Salbutamol inhibits ubiquitin-mediated survival motor neuron protein degradation in spinal muscular atrophy cells
Open Access
- 1 December 2015
- journal article
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 4, 351-356
Abstract
No abstract availableKeywords
Funding Information
- Singapore-MIT Alliance for Research and Technology Centre (H22-NANCHIIPPAN-012)
- Ministry of Education, Culture, Sports, Science and Technology (25461549)
This publication has 25 references indexed in Scilit:
- Spinal Muscular Atrophy: From Gene Discovery to Clinical TrialsAnnals of Human Genetics, 2013
- A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2Human Molecular Genetics, 2010
- In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproateAnnals of Neurology, 2006
- An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMNHuman Molecular Genetics, 2000
- 59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised diagnostic criteria 17–19 April 1998, Soestduinen, The NetherlandsNeuromuscular Disorders, 1999
- A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophyProceedings of the National Academy of Sciences, 1999
- Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7neurogenetics, 1997
- Identification of Proximal Spinal Muscular Atrophy Carriers and Patients by Analysis of SMNT and SMNC Gene Copy NumberThe American Journal of Human Genetics, 1997
- Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individualsHuman Molecular Genetics, 1995
- Identification and characterization of a spinal muscular atrophy-determining geneCell, 1995